-
1
المؤلفون: Danique Giesen, E. L. van der Veen, J.B.A.G. Haanen, A. J. van der Wekken, Derk Jan A. de Groot, Lucie Hijmering-Kappelle, Mathilde Jalving, P P van de Donk, H.J.M. Groen, M. N. Lub-de Hooge, Adrienne H. Brouwers, E.G.E. de Vries, Wim Timens, Iris C. Kok, B. van der Hiel, W Uyterlinde, Sjoerd G. Elias, G.A.P. (Geke) Hospers, J A Hooiveld, Thijo J N Hiltermann
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Annals of Oncology, 33(1), 80-88. Oxford University Press
Annals of Oncologyمصطلحات موضوعية: EXPRESSION, Oncology, medicine.medical_specialty, Biodistribution, PET/CT, medicine.medical_treatment, Standardized uptake value, Pembrolizumab, Internal medicine, PD-1, medicine, HETEROGENEITY, biology, medicine.diagnostic_test, business.industry, Melanoma, Cancer, Hematology, Immunotherapy, medicine.disease, PET, ANTIBODY, Positron emission tomography, SURVIVAL, biology.protein, pembrolizumab, immunotherapy, Zr-89, Antibody, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781376a45d3e69e26c46f1276c3106dcTest
https://doi.org/10.1016/j.annonc.2021.10.213Test -
2
المؤلفون: Elisabeth G.E. de Vries, Olga Vasiljeva, Margaret Nguyen, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge, Danique Giesen, Derk Jan A. de Groot, Sjoerd G. Elias, Laura Kist de Ruijter, Hong Lu, Iris C. Kok, Jahlisa S. Hooiveld-Noeken, Jourik A. Gietema, Mathilde Jalving
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Clinical Cancer Research, 27(19), 5325-5333. AMER ASSOC CANCER RESEARCH
مصطلحات موضوعية: Radioisotopes, Cancer Research, Biodistribution, medicine.diagnostic_test, business.industry, Spleen, Standardized uptake value, B7-H1 Antigen, Lymphatic system, medicine.anatomical_structure, Oncology, Pharmacokinetics, Positron emission tomography, Neoplasms, Positron-Emission Tomography, medicine, Humans, Tissue Distribution, Lymph, Bone marrow, Zirconium, Nuclear medicine, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cfa163ea7d36f883c4bb20efb84854Test
https://research.rug.nl/en/publications/2d030fe5-15cd-4f34-8746-215d667e6794Test -
3
المؤلفون: Arjen J. Witkamp, Joost Nederend, Andreas J A Bremers, Philip R. de Reuver, Wilhelmina M U van Grevenstein, Henk M.W. Verheul, Koen P. Rovers, Max J. Lahaye, Niels F. M. Kok, Jurriaan B. Tuynman, Checca Bakkers, Maartje Los, Ignace H. J. T. de Hingh, Anna M.J. Thijs, Patrick H. J. Hemmer, Alexandra R. M. Brandt-Kerkhof, Miriam Koopman, Onno Kranenburg, Petur Snaebjornsson, Marcel G. W. Dijkgraaf, Simon W. Nienhuijs, Arend G. J. Aalbers, Schelto Kruijff, Jacobus W. A. Burger, Tineke E. Buffart, Derk Jan A. de Groot, Esther van Meerten, Iris van 't Erve, Geert-Jan Creemers, Miranda Kusters, Pieter J. Tanis, Eva V. E. Madsen, Remond J.A. Fijneman, Kathelijn S. Versteeg, Djamila Boerma, Cornelis J A Punt, Marinus J. Wiezer
المساهمون: Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, VU University medical center, Epidemiology and Data Science, APH - Methodology, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642Test
JAMA Surgery, 156(8), 710-720. American Medical Association
JAMA surgery, 156(8), 710-720. American Medical Association
JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
JAMA Surgery, 156, 710-720
JAMA Surg
JAMA Surgery, 156, 8, pp. 710-720مصطلحات موضوعية: Male, PROGNOSIS, medicine.medical_treatment, CARCINOMATOSIS, MULTICENTER, Hyperthermic Intraperitoneal Chemotherapy, 030230 surgery, Peritoneal Neoplasms/secondary, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Randomized controlled trial, law, Adenocarcinoma/secondary, Adjuvant/adverse effects, Neoadjuvant therapy, Original Investigation, Bevacizumab/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, CANCER, Neoadjuvant Therapy, Fluorouracil/administration & dosage, Capecitabine/administration & dosage, 030220 oncology & carcinogenesis, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, medicine.drug, medicine.medical_specialty, Camptothecin/administration & dosage, Capecitabine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, REGRESSION, medicine, MANAGEMENT, Chemotherapy, Humans, Organoplatinum Compounds/administration & dosage, Perioperative Period, Response Evaluation Criteria in Solid Tumors, Aged, Colorectal Neoplasms/pathology, HIPEC, business.industry, Perioperative, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Irinotecan, Mitomycin/administration & dosage, Feasibility Studies, business, CONSENSUS
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375b682e7bd1c0c6ebfa96df3e48e33eTest
https://hdl.handle.net/11370/c9e531bb-9f62-460d-afc2-636baf20eec6Test -
4
المؤلفون: Emile B Veenstra, Derk Jan A. de Groot, Annemiek M E Walenkamp, Adrienne H. Brouwers, Walter Noordzij
المساهمون: Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Clinical Nuclear Medicine, 46(3), 195-200. LIPPINCOTT WILLIAMS & WILKINS
مصطلحات موضوعية: Adult, Male, F-18-DOPA, Octreotide, Sensitivity and Specificity, chemistry.chemical_compound, medicine, Organometallic Compounds, DOTA, Humans, Radiology, Nuclear Medicine and imaging, neoplasms, Retrospective Studies, Lung, biology, business.industry, PET tracer, Chromogranin A, General Medicine, Pet imaging, Middle Aged, Well differentiated, Dihydroxyphenylalanine, 18f dopa, Neuroendocrine Tumors, medicine.anatomical_structure, chemistry, tumor markers, Carbidopa, Positron-Emission Tomography, biology.protein, Ga-68-DOTATOC, Biomarker (medicine), Female, Nuclear medicine, business, neuroendocrine tumor, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd4b07fa496c9f0358bcf841f6e173fTest
https://hdl.handle.net/11370/f1173269-aa27-46d7-85e3-291ed6ff13c7Test -
5
المؤلفون: Andrés Cervantes, H.P. Knol, L. Østergaard, M.L. Lydrup, S.A. Radema, R.F. Schmitz, P. Nieboer, J. Hol, I. Edhemovic, K.C.M.J. Peeters, A. Johnsson, F.J.F. Jeurissen, Pieter J. Tanis, A.C.M. van de Luijtgaarden, P. Quarles an Ufford, H. Kim, Hein Putter, W.A. Bleeker, Tone Fokstuen, M E van Leerdam, K. Kovacs, A. Pronk, E.D. Kerver, L.G.H. Dewit, E. Garcia Granero, P.A. Nijenhuis, T. Fokstuen, S. Ottosson, P. Flygare, M.J. Safont, Iris D. Nagtegaal, F. Svendsen Jensen, C. Bratthäll, H.M. Ceha, L. Malmberg, P. Hede, W.M. van der Deure, G. Carlsson, J. Haux, Derk Jan A. de Groot, Esmée A Dijkstra, Renu R. Bahadoer, G.A.P. Nieuwenhuijzen, B. de Valk, B. Lindh, D. Hess, G.L. Beets, J.C. Bernal, A.M.E. Bruynzeel, R.M.P.H. Crolla, C. Kersten, P. Pfeiffer, S. Biondo, M.L. Silviera, Jannet C. Beukema, W.H. Schreurs, O. Hallböök, B.L. Lödén, A. Espí Macías, V. Velenik, L. Österlund, A. Slot, Geke A. P. Hospers, H. de Wilt, A.W.K.S. Marinelli, O. Lundberg, C. Radu, J. die Trill, I. Verbiené, P. Matthiessen, Mathijs P. Hendriks, J.H.M. Bekker, M. Walldén, V. Pachón, H.W. Kapiteijn, J.M. Immink, A. Piwowar, R. Salazar, L. Påhlman, P. Braam, K.E.J. Jensen, S. Festen, O. Mjåland, Elma Meershoek-Klein Kranenbarg, Jaume Capdevila, U. Palenius, K. Villmann, J.J. van der Vliet, Albert J. ten Tije, A. Berglund, Corrie A.M. Marijnen, G. Dafnis, J. Assarsson, J. Capdevila, J.W.T. Dekker, M. Grønlie Guren, G.J. Veldhuis, Q.A.J. Eijsbouts, G.J. Creemers, J.B. Tuynman, C.J.A. Punt, P.H.J.M. Veldman, J. Aparicio, Klaas Havenga, E.D. Geijsen, W.H. Steup, T. Rozema, K. Smedh, Lennart Blomqvist, J. de Boer, Cornelis J.H. van de Velde, S. Jangmalm, J.W.P. Vanstiphout, T.C. Stam, A.C.M. van den Bergh, Annet G H Roodvoets, Janet R. Vos, E.J.M. Siemerink, R.J.I. Bosker, Bengt Glimelius, A. Cervantes, E. Espin, Per Nilsson, A.J. Ten Tije, Ibrahim Edhemovic, Boudewijn van Etten, M. Tascilar, A.N. Nesbakken, G.A. Patijn, O. Reerink, Regina G. H. Beets-Tan, S. Skullman, H. Hörberg, P. Parinkh, G. Svaninger, M.B. Polée, D. Ten Bokkel Huinink, C. Hoff, A.F.T. Olieman, H. van den Berg, F.P. Peters, Torbjörn Holm, J.M. van Rooijen, M.P. Hendriks, J. Benedik, J.H. Svensson, A.L.T. Imholz
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiation Oncology, Internal medicine, VU University medical center, Ophthalmology, Amsterdam Neuroscience - Systems & Network Neuroscience, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiotherapy, Paediatric Oncology
المصدر: Lancet Oncology, 22, 29-42
Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045Test(20)30555-6
The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Oncology, 22, 1, pp. 29-42
The Lancet Oncology, 22(1), 29-42. ELSEVIER
The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group
lancet oncology, 22(1), 29-42. Lancet Publishing Groupمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Population, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, Folinic acid, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], medicine, Clinical endpoint, education, education.field_of_study, Performance status, business.industry, Total mesorectal excision, Oxaliplatin, Surgery, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business, Chemoradiotherapy, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d055e24de581f7d953a2dafec480d7Test
https://doi.org/10.1016/s1470-2045Test(20)30555-6 -
6
المؤلفون: Derk Jan A. de Groot, Anne M.L. Jansen, Mariette Labots, Wendy W.J. de Leng, Hanneke van der Wijngaart, Ann Hoeben, L.J. Zeverijn, Hans Gelderblom, Henk M.W. Verheul, Debbie Robbrecht, L.R. Hoes, Emile E. Voest, Erik van Werkhoven, Daphne L. van der Velden, J. Maxime van Berge Henegouwen, Paul Roepman, Paul Hamberg, Niven Mehra
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, Hematology, Research & Education, Neurology, Medical Oncology, Radiology and Nuclear Medicine, Graduate School, APH - Methodology, APH - Personalized Medicine
المصدر: Clinical Cancer Research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Clinical Cancer Research, 27, 6106-6114
Clinical Cancer Research, 27(22), 6106-6114. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research : an official journal of the American Association for Cancer Research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Van Der Wijngaart, H, Hoes, L R, Van Berge Henegouwen, J M, Van Der Velden, D L, Zeverijn, L J, Roepman, P, Van Werkhoven, E, De Leng, W W J, Jansen, A M L, Mehra, N, Robbrecht, D G J, Labots, M, De Groot, D J A, Hoeben, A, Hamberg, P, Gelderblom, H, Voest, E E & Verheul, H M W 2021, ' Patients with Biallelic BRCA1/2 Inactivation respond to Olaparib treatment across Histologic tumor types ', Clinical Cancer Research, vol. 27, no. 22, pp. 6106-6114 . https://doi.org/10.1158/1078-0432.CCR-21-1104Test
Clinical cancer research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Clinical Cancer Research, 27, 22, pp. 6106-6114مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, MAINTENANCE THERAPY, MULTICENTER, HOMOLOGY-DIRECTED REPAIR, OVARIAN-CANCER, VALIDATION, Olaparib, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], chemistry.chemical_compound, DOUBLE-BLIND, All institutes and research themes of the Radboud University Medical Center, Stable Disease, SDG 3 - Good Health and Well-being, Internal medicine, Clinical endpoint, Medicine, BREAST-CANCER, Loss function, 2-STAGE DESIGNS, business.industry, Wnt signaling pathway, Cancer, medicine.disease, RISKS, chemistry, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], PARP inhibitor, Toxicity, SENSITIVITY, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c98f524eeae4d08d3446ab9d9820a5Test
https://cris.maastrichtuniversity.nl/en/publications/6d297817-2a7a-4ceb-a790-898d766dde2fTest -
7
المؤلفون: Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge, Anthonie J. van der Wekken, Sjoukje F. Oosting, Derk Jan A. de Groot, Adrienne H. Brouwers, Rudolf S N Fehrmann, Pim P. van de Donk, Laura Kist de Ruijter
المصدر: Theranostics
مصطلحات موضوعية: 0301 basic medicine, T cell, medicine.medical_treatment, T-Lymphocytes, Cell, Medicine (miscellaneous), immune checkpoint inhibitor, CANCER-PATIENTS, Review, METABOLIC-ACTIVITY, positron emitting tomography, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Immune system, Neoplasms, Biomarkers, Tumor, BREAST-CANCER, Medicine, Humans, REGULATORY T-CELLS, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Immune Checkpoint Inhibitors, Tomography, Emission-Computed, Single-Photon, medicine.diagnostic_test, LIGAND 1 EXPRESSION, business.industry, Patient Selection, biomarkers, Immunotherapy, medicine.disease, molecular imaging, F-18-FDG PET/CT, RESPONSE EVALUATION, immunotherapy, METASTATIC MELANOMA PATIENTS, PD-L1 EXPRESSION, 030104 developmental biology, medicine.anatomical_structure, Positron emission tomography, 030220 oncology & carcinogenesis, Positron-Emission Tomography, TUMOR RESPONSE, Cancer research, Molecular imaging, business, Emission computed tomography
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b0c07e0bd89c9efeb7bee8236f96660Test
http://europepmc.org/articles/PMC6993216Test -
8
المصدر: Pharmacology & Therapeutics. 201:103-119
مصطلحات موضوعية: Bispecific antibody (bsAb), 0301 basic medicine, Oncology, medicine.medical_specialty, Bispecific antibody, MEDULLARY-THYROID CARCINOMA, medicine.drug_class, ANTITUMOR-ACTIVITY, medicine.medical_treatment, PRETARGETED RADIOIMMUNOTHERAPY, Cancer immunotherapy, Tumor cells, Monoclonal antibody, Epitope, 03 medical and health sciences, Clinical trials, 0302 clinical medicine, Drug Development, Neoplasms, Internal medicine, Antibodies, Bispecific, medicine, Animals, Humans, SINGLE-CHAIN ANTIBODY, Pharmacology (medical), Pretargeted Radioimmunotherapy, BITE ANTIBODY, Pharmacology, Antitumor activity, ANTIGEN-BINDING, biology, business.industry, TARGETED DELIVERY, PHASE-I, 030104 developmental biology, 030220 oncology & carcinogenesis, T-CELLS, biology.protein, Immunotherapy, MONOCLONAL-ANTIBODIES, Antibody, Antibody constructs, business, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fd2d450953eac4bd0cdc5e25edae8fTest
https://doi.org/10.1016/j.pharmthera.2019.04.006Test -
9
المؤلفون: Christiaan van der Leij, Krijn P. van Lienden, Jan J. J. de Vries, Nomdo S Renken, F. Daams, Ronald M. van Dam, C. Yung Nio, M. Liem, Thomas L. Bollen, Geert-Jan Creemers, Steffi J Rombouts, Judith de Vos-Geelen, Gijs A. Patijn, Maartje Los, Sebastiaan Festen, I. Quintus Molenaar, J. Nederend, Derk Jan A. de Groot, Rutger C G Bruijnen, Jan Willem B. de Groot, Joost G Blomjous, Leonie J. M. Mekenkamp, John J. Hermans, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Susana I S Patuleia, Johanna W. Wilmink, Thijs J Schouten, Maaike E Verweij, Lilly J H Brada, Hjalmar C. van Santvoort, Emile D. Kerver, Vincent E de Meijer, J.F.M. Pruijt, Annelie Vulink, Koop Bosscha, Frank J. Wessels, Maarten S. van Leeuwen, Marc G. Besselink, Marco B. Polee, Olivier R. Busch, Martijn R. Meijerink, M.S. Walma, Martijn W J Stommel
المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer biology and immunology, Ophthalmology, Internal medicine, VU University medical center, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137Test
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707مصطلحات موضوعية: Male, Antimetabolites, Antineoplastic, medicine.medical_specialty, Paclitaxel, FOLFIRINOX, medicine.medical_treatment, Locally advanced pancreatic cancer, Leucovorin, Adenocarcinoma, Irinotecan, Deoxycytidine, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], All institutes and research themes of the Radboud University Medical Center, Pancreatectomy, Albumins, Internal medicine, Pancreatic cancer, treatment strategies, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Prospective cohort study, Response Evaluation Criteria in Solid Tumors, Aged, Chemotherapy, business.industry, General Medicine, Middle Aged, medicine.disease, Gemcitabine, Neoadjuvant Therapy, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Oncology, Cohort, Treatment strategy, Female, Surgery, Fluorouracil, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8a66a9183508390e581990d356d615Test
https://doi.org/10.1016/j.ejso.2020.11.137Test -
10
المؤلفون: R.M. van Dam, I. H. J. T. de Hingh, V. E. de Meijer, Leonie J. M. Mekenkamp, Johanna W. Wilmink, Derk Jan A. de Groot, Martijn R. Meijerink, N. Haj Mohammad, J.F.M. Pruijt, Koop Bosscha, Gijs A. Patijn, M. Los, Lilly J H Brada, H.C. van Santvoort, G.J.M. Creemers, Marco B. Polee, Sebastiaan Festen, Geert A. Cirkel, J. de Vos-Geelen, Emile D. Kerver, I.Q. Molenaar, M.G. Besselink, M. Liem, J. A. Ropela, M.S. Walma, J.W.B. de Groot, Martijn W J Stommel
المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
Pancreatology, 21, 163-169
Pancreatology, 21(1), 163-169. Elsevier
Pancreatology, 21, 1, pp. 163-169
Pancreatology, 21(1), 163-169. S. Karger AG
Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BVمصطلحات موضوعية: Male, FOLFIRINOX, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Locally advanced pancreatic cancer, Kaplan-Meier Estimate, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Elderly, DISPARITIES, Registries, NAB-PACLITAXEL, Aged, 80 and over, OUTCOMES, Incidence (epidemiology), Age Factors, Gastroenterology, Chemoradiotherapy, Induction Chemotherapy, Middle Aged, CHEMOTHERAPY, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, 030211 gastroenterology & hepatology, Best supportive care, medicine.drug, Adult, medicine.medical_specialty, Young Adult, 03 medical and health sciences, AGE, Drug Therapy, Internal medicine, Pancreatic cancer, Post-hoc analysis, medicine, Humans, Aged, Chemotherapy, Hepatology, OLDER PATIENTS, business.industry, ADENOCARCINOMA, medicine.disease, Survival Analysis, Comorbidity, Gemcitabine, Pancreatic Neoplasms, GEMCITABINE, business, COMORBIDITY
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414ed7d7980dab4a07cdbd070c10f3dTest
https://research.vumc.nl/en/publications/01ec0bf4-0c27-4e80-99e6-7fc4c055e18fTest